Quarterly report pursuant to Section 13 or 15(d)

Note 21 - Segment Information: Schedule of Segment Information (Details)

v3.20.1
Note 21 - Segment Information: Schedule of Segment Information (Details) - USD ($)
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating income (loss) $ (236,723) $ (856,244)
Interest income 19,403 42,580
Interest expense 7,337 4,523
Depreciation and amortization 3,842 5,428
Cannabis and Medical Marijuana Segment    
Net revenue 12,538 120,089
Operating income (loss) (8,905) (606,697)
Interest income 980 20,679
Interest expense 0 0
Property additions 0 0
Depreciation and amortization 0 0
Facility Operations Related    
Net revenue 1,136,924 955,906
Operating income (loss) 34,176 17,179
Interest income 0 3
Interest expense 8,471 5,657
Property additions 3,329 8,159
Depreciation and amortization 2,640 2,653
Geography Eliminations    
Net revenue 0 0
Operating income (loss) (261,994) (266,726)
Interest income 18,423 21,898
Interest expense (1,134) (1,134)
Property additions 0 0
Depreciation and amortization 1,202 2,932
Consolidated    
Net revenue 1,149,462 1,075,995
Operating income (loss) (236,723) (856,244)
Interest income 19,403 42,580
Interest expense 7,337 4,523
Property additions 3,329 8,159
Depreciation and amortization $ 3,842 $ 5,585